Filing Details

Accession Number:
0001209191-19-003446
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-11 17:18:52
Reporting Period:
2019-01-09
Accepted Time:
2019-01-11 17:18:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649989 Outlook Therapeutics Inc. OTLK () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1191504 J Kurt Hilzinger C/O Outlook Therapeutics, Inc.
7 Clarke Drive
Cranbury NJ 08512
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-09 2,792 $0.73 98,629 No 4 P Direct
Common Stock Acquisiton 2019-01-10 6,053 $0.70 104,682 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.70 - $0.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.685 - $0.7493, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.